Abstract:With the development of high-throughput technology and the accumulation of biomedical data, the prior information of biological entity can be calculated from different aspects. Specifically, drug-drug similarities can be measured from target profiles, drug-drug interaction and side effects. Similarly, different methods and data sources to calculate disease ontology can result in multiple measures of pairwise disease similarities. Therefore, in computational drug repositioning, developing a dynamic method to optimize the fusion process of multiple similarities is a crucial and challenging task. In this study, we propose a multi-similarities bilinear matrix factorization (MSBMF) method to predict promising drug-associated indications for existing and novel drugs. Instead of fusing multiple similarities into a single similarity matrix, we concatenate these similarity matrices of drug and disease, respectively. Applying matrix factorization methods, we decompose the drug-disease association matrix into a drug-feature matrix and a disease-feature matrix. At the same time, using these feature matrices as basis, we extract effective latent features representing the drug and disease similarity matrices to infer missing drug-disease associations. Moreover, these two factored matrices are constrained by non-negative factorization to ensure that the completed drug-disease association matrix is biologically interpretable. In addition, we numerically solve the MSBMF model by an efficient alternating direction method of multipliers algorithm. The computational experiment results show that MSBMF obtains higher prediction accuracy than the state-of-the-art drug repositioning methods in cross-validation experiments. Case studies also demonstrate the effectiveness of our proposed method in practical applications. Availability: The data and code of MSBMF are freely available at https://github.com/BioinformaticsCSU/MSBMF. Corresponding author: Jianxin Wang, School of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, P. R. China. E-mail: jxwang@mail.csu.edu.cn Supplementary Data: Supplementary data are available online at https://academic.oup.com/bib.

Discovery of Novel Therapeutic Properties of Drugs from Transcriptional Responses Based on Multi-Label Classification

Scrank Infers Drug-Responsive Cell Types from Untreated Scrna-Seq Data Using a Target-Perturbed Gene Regulatory Network

Machine learning for drug repositioning: Recent advances and challenges

A machine learning approach to drug repositioning based on drug expression profiles: Applications to schizophrenia and depression/anxiety disorders

A Pathway Profile-Based Method for Drug Repositioning

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

Machine Learning and Deep Learning Strategies in Drug Repositioning

In silico drug repositioning based on drug-miRNA associations

Computational Drug Repositioning Using Collaborative Filtering Via Multi-Source Fusion

Computational drug repositioning: from data to therapeutics.

Accurate Drug Repositioning Through Non-tissue-Specific Core Signatures from Cancer Transcriptomes

Author Correction: Prediction of New Drug Indications Based on Clinical Data and Network Modularity

Prediction of Drug Pathway-based Disease Classes using Multiple Properties of Drugs

deepDR: a network-based deep learning approach to in silico drug repositioning

Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery

Computational Drug Repositioning Based on Multi-Similarities Bilinear Matrix Factorization.

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

Drug Repositioning by Prediction of Drug's Anatomical Therapeutic Chemical Code Via Network-Based Inference Approaches.

Biomedical Data and Computational Models for Drug Repositioning: a Comprehensive Review

Gene Signature-Based Drug Repositioning